SecBot SecBot
144 ·Filed Nov 4, 2026

NRIX

Nurix Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed12d 7h ago SEC0001950047-26-010683
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale of vested RSU shares. Monitor for any subsequent Form 4 filings to confirm execution, but no material impact is expected.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$14.84
T+0 close · Nov 4, 2026 · via day close
Latest settled
+5.12%
T+5 · $15.60 · next T+20 in 17d
Vs SPY
+1.83%
α at T+5
Latest observation
+1.31%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $14.84entry
  2. T+1 · 11d ago +3.10%α +2.79% · $15.30
  3. T+5 · 5d ago +5.12%α +1.83% · $15.60
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Hans van Houte, an officer of Nurix Therapeutics, filed a Form 144 notice of intent to sell 4,769 shares of common stock, with an approximate market value of $123,136 based on the filing date. The shares were acquired via restricted stock units that vested on October 30, 2026. This represents a relatively small portion of the company's $2.8B market cap and is a routine insider sale.

Key Facts

  • Hans van Houte, an officer of Nurix Therapeutics, filed Form 144 on 2026-11-04.
  • The proposed sale covers 4,769 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $123,135.58.
  • Shares were acquired via restricted stock units that vested on 2026-10-30.
  • The sale is planned to occur on or after 2026-11-04 on Nasdaq.
  • The company's market cap is approximately $2.8B, making this sale about 0.004% of market cap.

Financial Impact

Proposed sale of 4,769 shares worth approximately $123,136, representing a small fraction of the officer's holdings and company market cap.

dilution

Risk Factors

  • Insider sale may signal reduced conviction, though the small size relative to market cap limits concern.
  • The sale is not yet executed; the insider may choose not to sell.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010683
Document: 0001950047-26-010683-index.html0001950047-26-010683
Document: 0001950047-26-010683.txt0001950047-26-010683

Track record

33 reports on NRIX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +53.71% at T+20 after the Jun 8, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.17 Now $14.73 −2.90% settles Dec 15
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.41 Now $14.73 −4.41% settles Dec 15
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  6. Nov 4, 202612d ago 144 Neutral 2/10 Viewing Entry $14.84 Now $14.73 −0.74% settles Dec 4
  7. Nov 3, 202613d ago 144 Neutral 2/10 Entry $15.95 Now $14.73 −7.65% settles Dec 3
  8. Nov 3, 202613d ago 8-K Bearish 5/10 Entry $15.95 Now $14.73 +7.65% settles Dec 3
  9. Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $25.82 Now $14.73 −42.95% settles Dec 2
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $25.82 Now $14.73 −42.95% settles Dec 2
Showing 10 of 33

US Market Status

Market Closed · Opens Wed (9h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026